Plasma levels of bupivacaine and its metabolites after subacromial infusions in concentrations 2.5 or 5.0 mg/ml.
Merivirta
R M
RM
Department of Anaesthesiology, Intensive Care, Emergency Care and Pain Medicine of Turku University Hospital, Finland. riika.merivirta@tyks.fi
Kuusniemi
K S
KS
Hurme
S A
SA
Neuvonen
P J
PJ
Rautakorpi
P J
PJ
Olkkola
K T
KT
Leino
K A
KA
D016058:Analgesia, Patient-Controlled; D000701:Analgesics, Opioid / Q000008:administration & dosage / Q000627:therapeutic use; D000779:Anesthetics, Local / Q000008:administration & dosage / Q000009:adverse effects / Q000097:blood*; D002045:Bupivacaine / Q000008:administration & dosage / Q000009:adverse effects / Q000097:blood*; D002851:Chromatography, High Pressure Liquid; D004305:Dose-Response Relationship, Drug; D005260:Female; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D036502:Infusions, Intralesional; D008297:Male; D013058:Mass Spectrometry; D008875:Middle Aged; D009020:Morphine / Q000008:administration & dosage / Q000627:therapeutic use; D010147:Pain Measurement; D010149:Postoperative Pain / Q000188:drug therapy; D020250:Postoperative Nausea and Vomiting / Q000453:epidemiology; D012782:Shoulder; D020069:Shoulder Pain / Q000601:surgery
D000701:Analgesics, Opioid; D000779:Anesthetics, Local; D009020:Morphine; D002045:Bupivacaine